Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Ogan

Showing results (151-160 of 167) with videos related to

Pageof 17
Sort By:
Frontiers in Oncology|February 16, 2026
Case Report: Looks can deceive: acute postoperative progressive renal dysfunction and hyperkalemia without significant hydronephrosisReza Lahiji, Ahmet Yildirim, William Luke, et al.
Urology Practice|November 21, 2025
Why Radical vs Partial Nephrectomy Matters in Patients With Preexisting Renal Dysfunction: Exploring Chronic Kidney Disease Progression by StageReza Lahiji, Ernest A Morton, Lorenzo Storino Ramacciotti, et al.
The Oncologist|February 26, 2021
Baseline Modified Glasgow Prognostic Score Associated with Survival in Metastatic Urothelial Carcinoma Treated with Immune Checkpoint InhibitorsJacqueline T Brown, Yuan Liu, Julie M Shabto, et al.
Clinical Genitourinary Cancer|March 5, 2024
Linear Muscle Segmentation for Metastatic Renal Cell Carcinoma: Changes in Clinic-Friendly Estimation Predict Survival Following Cytoreductive NephrectomyEdouard H Nicaise, Benjamin N Schmeusser, Adil Ali, et al.
Journal for Immunotherapy of Cancer|July 30, 2021
Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitorsJacqueline T Brown, Yuan Liu, Julie M Shabto, et al.
The Oncologist|June 7, 2023
Immune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint InhibitorsGregory E Sanda, Julie M Shabto, Subir Goyal, et al.
JCO Oncology Practice|January 8, 2026
Erratum: Estimated Glomerular Filtration Rate Equations Overestimate Renal Function Compared With Measured Glomerular Filtration Rate Using 24-Hour Urine Creatinine ClearanceReza Lahiji, Ernest Allen Morton, Lorenzo Storino Ramacciotti, et al.
JCO Oncology Practice|December 16, 2025
Estimated Glomerular Filtration Rate Equations Overestimate Renal Function Compared With Measured Glomerular Filtration Rate Using 24-Hour Urine Creatinine ClearanceReza Lahiji, Ernest Allen Morton, Lorenzo Storino Ramacciotti, et al.
Genetics|January 30, 2024
A missense SNP in the tumor suppressor SETD2 reduces H3K36me3 and mitotic spindle integrity in DrosophilaJovan S Brockett, Tad Manalo, Hala Zein-Sabatto, et al.
Urologic Oncology|April 5, 2026
Laboratory paraneoplastic syndrome resolution is associated with reduced recurrence and improved survival in non-metastatic renal cell carcinomaReza Lahiji, Luke L Son, Susan Mumford, et al.
Pageof 17

Showing results (151-160 of 167) with videos related to

Sort By:
Pageof 17
Frontiers in Oncology|February 16, 2026
Case Report: Looks can deceive: acute postoperative progressive renal dysfunction and hyperkalemia without significant hydronephrosisReza Lahiji, Ahmet Yildirim, William Luke, et al.
Urology Practice|November 21, 2025
Why Radical vs Partial Nephrectomy Matters in Patients With Preexisting Renal Dysfunction: Exploring Chronic Kidney Disease Progression by StageReza Lahiji, Ernest A Morton, Lorenzo Storino Ramacciotti, et al.
The Oncologist|February 26, 2021
Baseline Modified Glasgow Prognostic Score Associated with Survival in Metastatic Urothelial Carcinoma Treated with Immune Checkpoint InhibitorsJacqueline T Brown, Yuan Liu, Julie M Shabto, et al.
Clinical Genitourinary Cancer|March 5, 2024
Linear Muscle Segmentation for Metastatic Renal Cell Carcinoma: Changes in Clinic-Friendly Estimation Predict Survival Following Cytoreductive NephrectomyEdouard H Nicaise, Benjamin N Schmeusser, Adil Ali, et al.
Journal for Immunotherapy of Cancer|July 30, 2021
Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitorsJacqueline T Brown, Yuan Liu, Julie M Shabto, et al.
The Oncologist|June 7, 2023
Immune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint InhibitorsGregory E Sanda, Julie M Shabto, Subir Goyal, et al.
JCO Oncology Practice|January 8, 2026
Erratum: Estimated Glomerular Filtration Rate Equations Overestimate Renal Function Compared With Measured Glomerular Filtration Rate Using 24-Hour Urine Creatinine ClearanceReza Lahiji, Ernest Allen Morton, Lorenzo Storino Ramacciotti, et al.
JCO Oncology Practice|December 16, 2025
Estimated Glomerular Filtration Rate Equations Overestimate Renal Function Compared With Measured Glomerular Filtration Rate Using 24-Hour Urine Creatinine ClearanceReza Lahiji, Ernest Allen Morton, Lorenzo Storino Ramacciotti, et al.
Genetics|January 30, 2024
A missense SNP in the tumor suppressor SETD2 reduces H3K36me3 and mitotic spindle integrity in DrosophilaJovan S Brockett, Tad Manalo, Hala Zein-Sabatto, et al.
Urologic Oncology|April 5, 2026
Laboratory paraneoplastic syndrome resolution is associated with reduced recurrence and improved survival in non-metastatic renal cell carcinomaReza Lahiji, Luke L Son, Susan Mumford, et al.
Pageof 17